Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-Center Phase I Dose Escalation/Response Trial to Evaluate Safety, Tolerability, and Anti-Tumor Efficacy of Intra-Arterial CBL0137 for Patients With Advanced Extremity Melanoma or Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03727789
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:52.307988+00:00
Published At
2024-03-27T00:00:00+00:00
Record Updated At
2024-03-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Cutaneous Melanoma of the Extremity", "Advanced Sarcoma of the Extremity", "Clinical Stage III Cutaneous Melanoma AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIB Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIC Cutaneous Melanoma AJCC v8", "Pathologic Stage IV Cutaneous Melanoma AJCC v8", "Recurrent Cutaneous Melanoma of the Extremity", "Recurrent Sarcoma of the Extremity", "Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-27"
protocolSection.identificationModule.nctId
"NCT03727789"
protocolSection.identificationModule.officialTitle
"A Single-Center Phase I Dose Escalation/Response Trial to Evaluate Safety, Tolerability, and Anti-Tumor Efficacy of Intra-Arterial CBL0137 for Patients With Advanced Extremity Melanoma or Sarcoma"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Cutaneous Melanoma of the Extremity (protocolSection.conditionsModule.conditions)
  • Advanced Sarcoma of the Extremity (protocolSection.conditionsModule.conditions)
  • Clinical Stage III Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Recurrent Cutaneous Melanoma of the Extremity (protocolSection.conditionsModule.conditions)
  • Recurrent Sarcoma of the Extremity (protocolSection.conditionsModule.conditions)
  • Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.